A recent study published in the journal Age and Aging has revealed that seniors and pensioners across the U.K. are being overly medicated for various diseases, making them an instant target among big pharmaceutical companies. A team of researchers at the Cambridge Institute of Public Health pooled data from more than 15,000 older people in order to accomplish the study. The patients have participated in two long-term health studies that began in the 1990s.
"We know that older people are at risk of being on too many drugs, without doctors always really understanding how they interact and what their side effects may be. This is why it is important that older people’s medicines are routinely reviewed," says Caroline Abrahams of the charity group Age UK.
The findings showed that the proportion of patients taking five or more different drugs per day grew from only 12 percent during the 1991-1994 period to 49 percent in the 2008-2011 period. The results also revealed that heart disease pills – such as statins and beta blockers for blood pressure – have grown by 230 percent. The drugs were also accounted for about 50 percent of all medications taken during the second period.
The research team also inferred that the Quality and Outcomes Framework program, which provides doctors with financial incentives to encourage drug prescription, may have played a central role in the marked increase in polypharmacy or excessive medication use. According to the experts, the initiative rewards physicians if they are able to accomplish goals for certain diseases such as heart disease, stroke, and asthma, as well as epilepsy, diabetes, and obesity.
"The Quality and Outcomes Framework (QOF) programme, like most clinical guidance on long-term condition management, targets a single disease. Guidelines are often dense and inflexible; thus, it is likely that clinicians who have limited consultation time, will prescribe focused on a single disease, rather than addressing the 'norm' of multi-morbidity, potentially leading to unnecessary prescribing and adverse effects. The observed increases in polypharmacy are to be expected as life expectancy increases and multi-morbidity rises. Programmes such as QOF … have resulted in earlier diagnosis, more proactive treatment and regular reviews of people with long-term conditions," the researchers told Daily Mail online.
Elderly population suddenly dying off for unexplained reasons, and it’s no longer coded as covid-19
By Lance D Johnson // Share
Corporations pushing mandatory coronavirus vaccines for customers, not just employees
By Ethan Huff // Share
Good fish, bad fish: How to avoid contaminants and support sustainably farmed fish
By Virgilio Marin // Share
Antimicrobial resistance up in animals raised for human consumption, warns study
By Michael Alexander // Share
Popular antidepressant is turning fish into “zombies,” new research shows
By Divina Ramirez // Share
Kirk’s death and Gaza conflict fuel false flag theories, media scrutiny, and narrative debates
By finnheartley // Share
Ukraine pushes war deeper into Russia with record drone flight to Siberian refinery
By isabelle // Share